Acorda Therapeutics to present at upcoming conferences

Dr. Ron Cohen will speak at the Leerink Partners 6th Annual Global Healthcare Conference.
Dr. Ron Cohen will speak at the Leerink Partners 6th Annual Global Healthcare Conference. | Contributed photo
Biotechnology company Acorda Therapeutics Inc., which is known for its work in neurological disorders, will present at two investor conferences this month. 
Dr. Ron Cohen, Acorda president and CEO, will speak at the Leerink Partners 6th Annual Global Healthcare Conference. The conference will be at 10:30 a.m. on Feb. 16, in New York, and will be available to live audio webcast at http://wsw.com/webcast/leerink28/acor.
Cohen will again present on behalf of the company at the RBC 2017 Healthcare Conference, also in New York. This event will be at 10 a.m. on Feb. 23. Just as the Leerink Partners conference, the RBC will be available for a live audio webcast at http://www.veracast.com/webcasts/rbc/healthcare2017/42205412441.cfm.